A nurse is teaching a client who has a new prescription for total parenteral nutrition (TPN). Which of the following information should the nurse include in the teaching?

A) "You should not feel anything more than a minor sting from the injection."
While this statement aims to reassure the client about the pain associated with the injection, it does not address the client's fear of needles or provide an alternative solution for medication administration. Therefore, it is not the most appropriate response in this situation.

B) "You must take this medication because there is no other option to treat this infection."
This response may increase the client's anxiety and resistance to receiving the medication. It fails to acknowledge the client's fear and does not offer a supportive approach to addressing the refusal. Additionally, there may be alternative treatment options available, making this statement inaccurate and potentially alarming for the client.

C) "Refusing the injection means you will not get better."
This response is confrontational and may further escalate the client's anxiety and resistance. It does not acknowledge or address the client's fear of needles, nor does it provide an alternative solution for medication administration. Using fear as a tactic to coerce the client into accepting the injection is not therapeutic and undermines the nurse-client relationship.

D) "I will discuss other treatment options with your provider."
This response acknowledges the client's fear and refusal of the injection while also demonstrating a commitment to finding alternative solutions for medication administration. By involving the healthcare provider in the discussion, the nurse can explore alternative treatment options that do not involve injections, such as oral medications or topical treatments. This approach respects the client's autonomy and promotes collaboration in decision-making, leading to a more positive and effective outcome for the client's care. Therefore, this is the most appropriate response in this situation.

A) PTT (Partial Thromboplastin Time): While the PTT is a laboratory test used to assess the intrinsic pathway of the coagulation cascade and monitor the effectiveness of heparin therapy, it is not routinely used to monitor warfarin therapy. Therefore, reviewing the PTT prior to administering warfarin is not necessary.

B) PT (Prothrombin Time): Prothrombin time measures the extrinsic pathway of the coagulation cascade and is commonly used to monitor warfarin therapy. Since warfarin works by inhibiting vitamin K-dependent clotting factors, such as factors II, VII, IX, and X, monitoring the PT allows for the assessment of the anticoagulant effect of warfarin and helps guide dosing adjustments. Therefore, reviewing the PT prior to administering warfarin is essential to ensure appropriate anticoagulation therapy.

C) WBC (White Blood Cell Count): The white blood cell count is not directly related to warfarin therapy monitoring. While an elevated white blood cell count may indicate infection, it is not specific to warfarin therapy and does not influence the administration of the medication.

D) Total iron-binding capacity: Total iron-binding capacity is a laboratory test used to assess iron status and is not relevant to monitoring warfarin therapy. It measures the body's ability to bind and transport iron in the blood, and its results are not indicative of warfarin's anticoagulant effect or dosage adjustments.